AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
BRILINTA has 9.8 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: BRILINTA (brilinta.com)
This is a low-BS pharmaceutical site that prioritizes clinical data over creative marketing. While the technical SEO and schema implementation are non-existent, the forensic evidence (patient counts, median trial lengths, specific indications) proves significant substance behind the drug’s claims.
Implement H1 tags on all pages to clearly define indications (e.g., ‘BRILINTA for Acute Ischemic Stroke’). Deploy MedicalWebPage and Drug schema to provide technical authority and link to the brand’s AstraZeneca heritage. Update the Medicare formulary data, which is currently over five years old. Add direct outbound citations to the peer-reviewed clinical publications for the PLATO and PEGASUS trials.
The site exhibits high information density, favoring clinical specifics over marketing power words. Specific metrics like the ‘median of 2.75 years’ for CAD studies and ‘over 11,000 patients’ for stroke studies provide high substance. Fluff is limited to regulatory functional headings like [H3] FOR PEOPLE and [H3] Approved Use, which, while generic, serve a structural purpose rather than a promotional one.
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
There is virtually zero semantic drift between the homepage and sub-pages. The homepage establishes three primary therapeutic tracks (Heart Attack, CAD, Stroke) which are directly fulfilled by the acs.html, cad.html, and stroke.html pages with matching clinical evidence and specific risk-reduction claims. The ‘Enterprise’ promise vs ‘Cheap’ delivery pattern is absent here.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
Trust theatre is not present in its typical form; the review_count is 0 across all pages, avoiding the common BS pattern of unverified testimonial stars. However, the site suffers from a proof path deficiency, with a proof_links_count of only 1-2 per page, and some key performance claims like ‘worked better than Plavix’ lack direct outbound links to the source peer-reviewed studies (e.g., PLATO trial) within the primary text body.
Proof density is high regarding clinical metrics (mentioning 19,000 and 11,000 patient studies), but chronologically stale. The Medicare Part D data cited is from February 16, 2021, which is 63 months old relative to the May 2026 system date, reducing the credibility of the financial proof points.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The site uses a heavy commodity template typical of US pharmaceutical brands, including mandatory [H2] IMPORTANT SAFETY INFORMATION blocks and ‘as low as $5’ savings cards. While ticagrelor is a unique chemical entity, the positioning (Better than [Competitor]) and value prop cliches (Understanding Your Stroke) follow a highly standardized industry fingerprint.
Authority gaps are primarily technical; every crawled page is missing a valid H1 tag, and the schema_json is null across the board. There is no Person schema or digital footprint for medical directors or lead scientists, though the AstraZeneca affiliation (mentioned in the terms) provides corporate authority that is not properly reflected in structured data.
The disconnect is minimal. Bold claims such as ‘proven to reduce the risk of another heart attack’ are immediately contextualized with specific study parameters, such as ’12 months in patients who were recently hospitalized.’ The site demonstrates what it claims through clinical N-counts rather than abstract ‘innovation’ talk.
Medical Devices, Pharma & Biotech BS: BRILINTA (brilinta.com)
The site content confirms a high-fidelity match with the Pharma and Biotech industry, specifically focusing on cardiovascular therapeutic areas. The presence of ‘Boxed Warnings,’ ‘Safety Information,’ and comparative clinical trial data (ticagrelor vs. clopidogrel/Plavix) is consistent with FDA-regulated pharmaceutical communication.
A page that loads perfectly for users can still return an empty shell to an AI crawler. Examine the Crawlability Technical Guide and understand why script free extraction is the real measure of visibility.
“The BS score of 31 is driven by a lack of structured data and technical SEO failures (Pillar 5) and the use of stale financial evidence (Pillar 3). It remains low overall because the site avoids marketing hyperbole and provides verifiable clinical metrics for every primary claim.”